| Structure |
Chemical Name |
CAS |
MF |
 |
4-BROMOMETHYLBIPHEBYL-2'-CARBOXYLIC ACID |
150766-86-2 |
C14H11BrO2 |
 |
Letrozole Impurity |
|
|
 |
Parecoxib Impurity J |
|
|
![6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one](/CAS/20180702/GIF/CB43038765.gif) |
6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one |
|
C38H40N4O4S |
 |
Linagliptin Impurity J |
|
|
 |
Linagliptin Impurity Q |
|
|
 |
(R)-2-(((1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)-4-fluorobenzonitrile |
|
C26H24F2N6O2 |
 |
Rosuvastatin Calcium Impurity |
2514620-36-9 |
C22H28FN3O6S |
 |
Canagliflozin Monoacetyl Impurity |
|
|
 |
Etoricoxib Impurity 13 |
1817735-82-2 |
C25H20ClN3O3S |
 |
Mirabegron Impurity 11 |
1684452-85-4 |
C21H24N4O2S |
 |
Riociguat Impurtiy 2 |
|
|
 |
Topiroxostat Impurity 9 |
577778-82-6 |
C13H8N6O |
 |
Vonoprazan Impurity F |
|
|
 |
Vortioxetine Impurity 15 |
2099147-02-9 |
C28H34N4S2 |
 |
Dapagliflozin Impurity H |
|
|
 |
Dapoxetine Impurity C |
|
|
 |
Iodixanol Impurity |
|
|
 |
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
 |
Ribavirin Imp. EP) |
|
|
 |
Sertraline EP Impurity |
|
C17H17Cl2N |
 |
Vildagliptin Related Compound G |
1616662-84-0 |
C12H20N4O3 |
 |
3-ethyl 5-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
158151-92-9 |
C22H29ClN2O5 |
 |
Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate |
1234321-81-3 |
C13H12F3NO3 |
 |
FG-4592 intermediate 8 |
1509958-20-6 |
C20H17NO6 |
 |
Parecoxib Sodium Imp.E |
|
|
 |
Trelagliptin Impurity 7 |
|
|
 |
Pramipexole impurity II |
|
|
![tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate](/CAS/20180629/GIF/1651214-74-2.gif) |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
1651214-74-2 |
C29H37N7O4 |
 |
Prasugrel Impurity 4 HCl |
1618107-96-2 |
C20H22Cl2FNO3S |
 |
Tofacitinib Impurity K |
|
|
 |
N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine |
1502829-45-9 |
C29H37ClFN5O4 |
 |
5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one |
24021-90-7 |
C3H5N3O2 |
![( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester )](/CAS/20180702/GIF/475084-96-9.gif) |
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) |
475084-96-9 |
C29H37N3O3 |
 |
N-(4-Hydroxymethylbenzyl) Cyclam |
176252-20-3 |
C18H32N4O |
 |
Alvimopan Impurity 3 |
|
|
 |
Nicergoline Impurity G |
|
|
 |
Isavuconazole Impurity 1 |
2069200-13-9 |
C13H12F2N4O |
 |
Sofosbuvir Impurity23 |
|
|
 |
Tacrolimus Impurity 1 |
|
|
 |
Bisoprolol EP Impurity F |
1798418-82-2 |
C18H31NO4 |
 |
Pantoprazole EP Impurity F |
721924-06-7 |
C17H17F2N3O4S |
 |
Rosuvastatin EP Impurity E |
|
|
![(6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-pivalamido-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/20180703/GIF/CB43159611.gif) |
(6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-pivalamido-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
1798390-48-3 |
C16H20N4O4S3 |
 |
(S)-ethyl 3-((R)-5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylate(DD) |
|
|
 |
Lincomycin EP Impurity B |
37744-65-3 |
C18H32N2O6S |
 |
Roxithromycin EP Impurity D |
134931-00-3 |
C41H76N2O15 |
 |
2-(pentan-3-yloxy)acetaldehyde |
1141364-90-0 |
C7H14O2 |
 |
Cabozantinib Impurity B |
|
|
![(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine](/CAS/20180529/GIF/1223404-88-3.gif) |
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine |
1223404-88-3 |
C16H15F2N5 |
 |
Ceftazidime Ep Impurity H |
1354396-23-8 |
C23H24N6O7S2 |
 |
Parecoxib Sodium Impurity 14 |
1709956-89-7 |
C19H18N2O4S |
![Benzoic acid, 2-[(methylamino)sulfonyl]-](/CAS/20180529/GIF/125372-22-7.gif) |
Benzoic acid, 2-[(methylamino)sulfonyl]- |
125372-22-7 |
C8H9NO4S |
![1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2)](/CAS/20180808/GIF/126517-38-2.gif) |
1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2) |
126517-38-2 |
C19H24Cl4N2O |
 |
Benzene,1-ethoxy-4-(phenylmethyl)- |
35672-52-7 |
C15H16O |
 |
Donepezil Impurity |
36159-03-2 |
C22H22O5 |
 |
tert-Butyl 4-(4-nitropyridin-3-yl)piperazine-1-carboxylate |
1774898-55-3 |
C14H20N4O4 |
 |
4-(2-Aminophenoxy)-N-methylpicolinamide |
1153328-25-6 |
C13H13N3O2 |
 |
Bupivacaine Impurity |
780736-98-3 |
C14H20N2O |
![rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine](/CAS/20210111/GIF/161594-54-3.gif) |
rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine |
161594-54-3 |
C14H20N2 |
 |
1,2-bis(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethane |
51299-16-2 |
C24H28F6N4 |
 |
(R)-N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine |
802918-35-0 |
C22H24F3N |
 |
Demiditraz racemate |
944263-08-5 |
C13H16N2 |
 |
Ropivacaine-iPr |
175888-75-2 |
C17H26N2O |
 |
Demiditraz IMpurity |
944267-48-5 |
C19H18N2O |
 |
Betamethasone EP Impurity F |
330157-04-5 |
C22H28O4 |
 |
Capecitabine Impurity 8 |
|
|
 |
Carfilzomib Impurity D |
|
|
 |
Cefodizime Impurity 4 |
|
|
 |
Cefradine impurity 5 |
1379292-16-6 |
C10H17NO2 |
 |
Clopidogrel Impurity 13 |
2173294-69-2 |
C16H16ClNO5S2 |
 |
DecitaBine Impurity 12 |
|
|
 |
Erlotinib Impurity 28 |
|
|
 |
Fosaprepitant Impurity 12 |
172673-19-7 |
C23H22F7N4O6P |
 |
Ibuprofen Impurity 2 |
|
C13H18O2 |
 |
Imatinib Impurity 9 |
|
|
 |
Isavuconazole Impurity 22 |
|
|
 |
Isavuconazole Impurity 28 |
|
|
 |
Levothyroxine Impurity 16 |
909279-46-5 |
C15H11ClI3NO4 |
 |
Linagliptin Impurity 42 |
|
|
 |
PalBociclib Impurity 25 |
|
|
 |
Posaconazole Impurity 13 |
357189-98-1 |
C37H40F2N8O6 |
 |
Posaconazole Impurity 25 |
1042398-26-4 |
C16H19F2IO3 |
 |
Posaconazole Impurity 42 |
357189-96-9 |
C36H40F2N8O5 |
 |
Posaconazole Impurity 65 |
2947625-11-6 |
C60H69F2N13O7 |
 |
Pramipexole Dimer Impurity (Mixture of Diastereomers) |
1147937-31-2 |
C13H23N3S |
 |
Sitafloxacin Impurity 1 |
|
C19H19ClF2N4O2 |
 |
Sitagliptin Impurity 25 |
|
|
 |
sofosBuvir impurity 47 |
|
|
 |
SofosBuvir Impurity 64 |
|
|
 |
Tofacitinib Impurity W |
|
|
 |
Trelagliptin Impurity 21 |
|
|
 |
2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine |
117976-92-8 |
C10H14ClNO2 |
 |
Oxytocin Impurity 3 |
|
|
 |
Rosuvastatin Impurity 158 |
|
|
 |
Rosuvastatin Impurity 139 |
|
|
 |
Rosuvastatin Impurity 124 |
|
|
 |
4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro- |
79617-95-1 |
C17H17Cl2N |
 |
Ertapenem Impurity A(USP) |
|
|
![D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel-](/CAS/20210305/GIF/2740644-40-8.gif) |
D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel- |
2740644-40-8 |
C14H22N2O6 |